Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.
about
Stem cell donation--what advice can be given to the donor?Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantationThe Primary Study of CD90(+)CD34(-)and Sca-1(+) Stem Cells Mobilized by EPO Plus G-CSF in Mice.Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent eraAllogeneic transplant physician and center capacity in the United States.High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia.Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations.Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their ChildTransplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective reviewAcute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation.Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9).The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia.Allogeneic stem cell transplantation for acute myeloid leukemia.Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group.Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia.Sleepiness, Fatigue, Behavioral Functioning, and Quality of Life in Survivors of Childhood Hematopoietic Stem Cell Transplant.Profile of Inflammation-Associated Proteins in Early Post-Transplant Samples of Patients After Allogeneic Hematopoietic Stem Cell Transplantation: a Preliminary Study.
P2860
Q24626108-436F67F6-0627-4DD2-8EEA-B823E986FC8EQ26851000-7EF8BBDD-A839-49EA-8273-842C9E1BC807Q33614714-FB2193AB-2C2A-42EF-9D3E-A2AABBA9E8F0Q33862876-A55377C3-BCF3-4AD1-825C-E77D58937301Q34645259-1B466455-09BB-4F2C-988E-245A0682F881Q34749365-F97BBA30-7DBE-4C28-BADB-D33E59F895FCQ35043072-AE97FCBC-91C0-4C0F-8DDB-C3A326A3FAA0Q35112199-DA702FC0-F159-4A7D-9FD3-B7EF2857F462Q35871747-1828D4B2-F03A-400C-B249-5B3B019E460AQ36100435-36A93F68-5E24-4EF0-A6C4-BD0E2EB4FF55Q36433335-BB87AB94-08F5-46CC-A17A-26B4CF68E90FQ36445618-34C1DBAE-A3C7-4FEF-91B2-1482E964E29FQ37233236-F79526C2-DABF-41F0-99FA-29C3989FAE54Q37526791-74A50E69-3C8A-4386-B9DA-B0D1692CAE13Q37642540-2E8F4D51-52E5-4C04-BC17-73D698DFD5E8Q37670062-5EDE7D18-1B93-4C87-818A-D49CD2E74C03Q39420711-83F8176E-A0CB-4CD8-9601-CE8C60EBF2C1Q42765065-CB423765-84B9-4B43-8B0C-6B0A3EE8BFAEQ43856934-9ACFE3B5-8828-4BDC-928F-62C7688D0D9EQ45210269-F5E7CD05-74A7-47F5-A91D-D39AF8E62A23Q47796311-561FAED5-0255-481D-B263-D960F757781DQ48355836-8135C9C8-E48A-40A2-83D9-2E3A38BF9894
P2860
Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Twenty years of unrelated dono ...... National Marrow Donor Program.
@en
Twenty years of unrelated dono ...... National Marrow Donor Program.
@nl
type
label
Twenty years of unrelated dono ...... National Marrow Donor Program.
@en
Twenty years of unrelated dono ...... National Marrow Donor Program.
@nl
prefLabel
Twenty years of unrelated dono ...... National Marrow Donor Program.
@en
Twenty years of unrelated dono ...... National Marrow Donor Program.
@nl
P2093
P1476
Twenty years of unrelated dono ...... National Marrow Donor Program.
@en
P2093
Dennis L Confer
Gene O Nelson
Margaret L MacMillan
Pintip Chitphakdithai
Roberta J King
Stella M Davies
P356
10.1016/J.BBMT.2008.05.019
P433
P577
2008-09-01T00:00:00Z